Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-25 · accession 0001194020-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-26 | 2026-02-25 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | A - Grant | $0.00 | +2,500 | 6,394 | +64% | $0 |
| D | 2026-02-26 | 2026-02-25 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | F - Tax | $50.69 | -1,279 | 5,115 | -20% | -$64.8K |
| D | 2026-02-26 | 2026-02-25 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | D - Sale to Iss | $0.00 | -2,500 | 2,500 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-25 | A | A | 2,500 | $0.00 | 6,394 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-25 | F | D | 1,279 | $50.69 | 5,115 | D | — | — | (F1) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
| 3 | Derivative | Restricted Stock Unit | 2026-02-25 | D | D | 2,500 | $0.00 | 2,500 | D | — · — to — | 2,500 Common Stock | (F2) Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. (F3) These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. |